Have a personal or library account? Click to login
Clinical Features and Disease Course of Cancer Patients Infected with Sars-Cov-2 During Anticancer Treatments Cover

Clinical Features and Disease Course of Cancer Patients Infected with Sars-Cov-2 During Anticancer Treatments

EABR. Experimental and Applied Biomedical Research
Volume 24 (2023): Issue 4 (December 2023)
By: Aleksandra Babić,  Jelena Milin-Lazović,  Sanja Milenković,  Jelena Dobrić,  Zlata Hufnagel,  Nenad Miladinović,  Sofija Milanović,  Marina Stojanović,  Sara Filipović,  Aleksandar Gavrić and  Nikola Borlja  
Open Access
|Jan 2024

Metrics

DOI: https://doi.org/10.2478/sjecr-2020-0054 | Journal eISSN: 2956-2090 | Journal ISSN: 2956-0454
Journal RSS Feed
Language: English
Page range: 277 - 287
Submitted on: Oct 6, 2020
|
Accepted on: Nov 30, 2020
|
Published on: Jan 2, 2024
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
SARS-CoV-2,
COVID-19,
cancer,
chemotherapy,
radiotherapy
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other

© 2024 Aleksandra Babić, Jelena Milin-Lazović, Sanja Milenković, Jelena Dobrić, Zlata Hufnagel, Nenad Miladinović, Sofija Milanović, Marina Stojanović, Sara Filipović, Aleksandar Gavrić, Nikola Borlja, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 24 (2023): Issue 4 (December 2023)Next article